loadpatents
name:-0.029613018035889
name:-0.021321058273315
name:-0.015642166137695
Sprengeler; Paul A. Patent Filings

Sprengeler; Paul A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sprengeler; Paul A..The latest application filed is for "crystalline forms of mnk inhibitors".

Company Profile
13.19.25
  • Sprengeler; Paul A. - Escondido CA
  • Sprengeler; Paul A. - San Diego CA
  • Sprengeler, Paul A. - El Granada CA
  • Sprengeler; Paul A. - Merion PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
EIF4A-inhibiting compounds and methods related thereto
Grant 11,440,917 - Ernst , et al. September 13, 2
2022-09-13
Crystalline Forms Of Mnk Inhibitors
App 20220119387 - REICH; Siegfried H. ;   et al.
2022-04-21
Piperidine-substituted Mnk Inhibitors And Methods Related Thereto
App 20220096472 - Ernst; Justin T. ;   et al.
2022-03-31
EIF4E-inhibiting compounds and methods
Grant 11,286,268 - Sperry , et al. March 29, 2
2022-03-29
Mnk Inhibitors And Methods Related Thereto
App 20210338673 - Reich; Siegfried H. ;   et al.
2021-11-04
Crystalline forms of MNK inhibitors
Grant 11,130,757 - Reich , et al. September 28, 2
2021-09-28
Piperidine-substituted Mnk inhibitors and methods related thereto
Grant 11,083,727 - Ernst , et al. August 10, 2
2021-08-10
Pyrrolo-, pyrazolo-, imidazo-pyrimidine and pyridine compounds that inhibit MNK1 and MNK2
Grant 11,014,926 - Sprengeler , et al. May 25, 2
2021-05-25
Eif4a-inhibiting Compounds And Methods Related Thereto
App 20200339590 - Ernst; Justin T. ;   et al.
2020-10-29
Benzimidazole-indole inhibitors of Mnk1 and Mnk2
Grant 10,793,551 - Ernst , et al. October 6, 2
2020-10-06
Crystalline Forms Of Mnk Inhibitors
App 20200131179 - Reich; Siegfried H. ;   et al.
2020-04-30
EIF4A-inhibiting compounds and methods related thereto
Grant 10,577,378 - Ernst , et al.
2020-03-03
Pyrrolo-, Pyrazolo-, Imidazo-pyrimidine And Pyridine Compounds That Inhibit Mnk1 And Mnk2
App 20190330216 - Sprengeler; Paul A. ;   et al.
2019-10-31
Piperidine-Substituted Mnk Inhibitors and Methods Related Thereto
App 20190275039 - Ernst; Justin T. ;   et al.
2019-09-12
Mnk Inhibitors And Methods Related Thereto
App 20190209560 - Reich; Siegfried H. ;   et al.
2019-07-11
Isoindoline, Azaisoindoline, Dihydroindenone And Dihydroazaindenone Inhibitors Of Mnk1 And Mnk2
App 20190152988 - Sprengeler; Paul A. ;   et al.
2019-05-23
Benzimidazole-indole Inhibitors Of Mnk1 And Mnk2
App 20190119256 - ERNST; Justin T. ;   et al.
2019-04-25
Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of Mnk1 and Mnk2
Grant 10,112,955 - Sprengeler , et al. October 30, 2
2018-10-30
Eif4a-inhibiting Compounds And Methods Related Thereto
App 20180298017 - ERNST; Justin T. ;   et al.
2018-10-18
Piperidine-Substituted Mnk Inhibitors and Methods Related Thereto
App 20180228803 - ERNST; Justin T. ;   et al.
2018-08-16
Heterocyclic compounds that inhibit the kinase activity of Mnk useful for treating various cancers
Grant 10,000,487 - Sprengeler , et al. June 19, 2
2018-06-19
eIF4A-inhibiting compounds and methods related thereto
Grant 9,957,277 - Ernst , et al. May 1, 2
2018-05-01
Mnk Inhibitors And Methods Related Thereto
App 20180085368 - Reich; Siegfried H. ;   et al.
2018-03-29
MNK inhibitors and methods related thereto
Grant 9,814,718 - Reich , et al. November 14, 2
2017-11-14
Mnk Inhibitors And Methods Related Thereto
App 20170266185 - Reich; Siegfried H. ;   et al.
2017-09-21
MNK inhibitors and methods related thereto
Grant 9,669,031 - Reich , et al. June 6, 2
2017-06-06
Heterocyclic Compounds That Inhibit The Kinase Activity Of Mnk Useful For Treating Various Cancers
App 20170145009 - SPRENGELER; Paul A. ;   et al.
2017-05-25
Eif4a-inhibiting Compounds And Methods Related Thereto
App 20170145026 - ERNST; Justin T. ;   et al.
2017-05-25
Isoindoline, Azaisoindoline, Dihydroindenone And Dihydroazaindenone Inhibitors Of Mnk1 And Mnk2
App 20170121346 - Sprengeler; Paul A. ;   et al.
2017-05-04
Pyrrolo-, Pyrazolo-, Imidazo-pyrimidine And Pyridine Compounds That Inhibit Mnk1 And Mnk2
App 20170121339 - Sprengeler; Paul A. ;   et al.
2017-05-04
Mnk Inhibitors And Methods Related Thereto
App 20160317536 - Reich; Siegfried H. ;   et al.
2016-11-03
Mnk inhibitors and methods related thereto
Grant 9,382,248 - Reich , et al. July 5, 2
2016-07-05
Mnk Inhibitors And Methods Related Thereto
App 20150376181 - Reich; Siegfried H. ;   et al.
2015-12-31
Fused ring heterocycle kinase modulators
Grant 8,268,994 - Arnold , et al. September 18, 2
2012-09-18
Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators
Grant 8,158,647 - Blaney , et al. April 17, 2
2012-04-17
Pyrrolo-pyridine kinase modulators
Grant 7,709,645 - Arnold , et al. May 4, 2
2010-05-04
Fused Ring Heterocycle Kinase Modulators
App 20100036118 - Arnold; William D. ;   et al.
2010-02-11
Fused ring heterocycle kinase modulators
Grant 7,626,021 - Arnold , et al. December 1, 2
2009-12-01
Pyrrolo-pyridine Kinase Modulatiors
App 20090143352 - Arnold; William D. ;   et al.
2009-06-04
Substituted Pyrrolopyridines And Pyrazolopyridines As Kinase Modulators
App 20090005356 - Blaney; Jeffrey M. ;   et al.
2009-01-01
Fused Ring Heterocycle Kinase Modulators
App 20070287711 - Arnold; William D. ;   et al.
2007-12-13
Novel phenyl derivatives as inducers of apoptosis
App 20050026929 - Cai, Sui Xiong ;   et al.
2005-02-03
Non-peptide peptidomimetics
Grant 6,197,963 - Hirschmann , et al. March 6, 2
2001-03-06
Peptides peptide analogs peptidomimetics and other small molecules useful for inhibiting the activity of ribonucleotide reductase
Grant 6,030,942 - Cooperman , et al. February 29, 2
2000-02-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed